1.	Phase III Randomized, Double-Blind Study of Liposomal Amphotericin B vs Standard Formulation Amphotericin B for Empiric Treatment of Persistent Febrile Neutropenia Unresponsive to Broad Spectrum Antibacterial Agents (Summary Last Modified 11/95) Phase: Phase III Type: Supportive care Status: Completed Age: 2 to 80 Sponsor: NCI Protocol IDs: NCI-95-C-0131A
2.	Phase III Randomized Study of Voriconazole Compared to Liposomal Amphotericin B as Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia (Summary Last Modified 09/1999) Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: NCI-98-C-0063, PFIZER-150-603
3.	Phase III Randomized Study Comparing Urokinase With Heparin in Preventing Infection and Occlusion in Central Venous Catheters in Children With Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 3 months-21 years Sponsor: NCI Protocol IDs: CCG-S921
4.	Phase III Study of Voriconazole in Patients With Invasive Fungal Infections (Summary Last Modified 01/2001) Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI Protocol IDs: NCI-99-C-0094B, NCI-99-C-0094
5.	Phase III Randomized Study of Nystatin in Patients Receiving High Dose Interleukin-2 (Summary Last Modified 07/2000) Phase: Phase III Type: Supportive care Status: Completed Age: 16 to 65 Sponsor: NCI Protocol IDs: NCI-99-C-0097
6.	Phase III Randomized Study of FK463 Versus Fluconazole in the Prevention of Fungal Infections in Patients Undergoing Autologous or Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 6 months and over Sponsor: NCI Protocol IDs: NCI-00-C-0014, MCC-12202
7.	Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Phase: Phase III Type: Supportive care Status: Completed Age: 16 and over Sponsor: NCI, Other Protocol IDs: 00-085, MSKCC-00085, MERCK-026-01, NCI-G00-1898, NCT00008359
8.	Phase III Randomized Study of Levofloxacin Versus Cefepime in Cancer Patients With Fever and Neutropenia (Summary Last Modified 12/2001). Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0006093, MCNEIL-CAPSS-118, NCI-G01-1965, NCT00020865
9.	Phase III Prophylactic Passive Immunization Against Infection Utilizing Intravenous Immunoglobulin in Cancer Patients Undergoing Chemotherapy Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: NCI-83-C-192, NCI-T83-1282N, T83-1282
10.	Phase III Randomized Study of Initial Empiric Antimicrobial Therapy with TMP-SMX/Erythromycin and Other Antibiotics as Indicated vs Pretreatment Bronchoalveolar Lavage and Pathogen-Specific Therapy in Immunocompromised Patients with Diffuse Interstitial Pneumonitis (Summary last modified 06/97) Phase: Phase III Type: Supportive care Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: NCI-86-C-26, NCI-T86-0081N, T86-0081
11.	Phase III Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Fluconazole in the Early Empirical Treatment of Suspected Fungal Infections in Febrile Neutropenic Patients with Leukemia or Lymphoma (Summary Last Modified 07/94) Phase: Phase III Type: Supportive care Status: Completed Age: at least 2 years Sponsor: NCI Protocol IDs: NCI-88-C-154A, NCI-T88-0184N, T88-0184
12.	Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 2 to 12 Sponsor: NCI, NHLBI Protocol IDs: 416, BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803
13.	American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU98308, U10CA081851, WFU-07-02-03, NCT00752895
14.	Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: NCI, Other Protocol IDs: 1322.00, FHCRC-1322.00, NCI-H99-0030, CDR0000067050, NCT00003883
15.	Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: Any age Sponsor: NCI, Other Protocol IDs: 1379.00, FHCRC-1379.00, NCI-G01-1929, CDR0000068540, NCT00014391
16.	Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI, Other Protocol IDs: 1603.00, FHCRC-1603.00, NCI-H02-0092, CDR0000256871, NCT00045292
17.	Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 2 and over Sponsor: NCI, Other Protocol IDs: 1290.00, FHCRC-1290.00, NCI-G01-1939, CDR0000068593, NCT00016081
18.	Phase I/II Study of Amphotericin B-Lipid Complex (AmBisome) in Immunocompromised Pediatric Patients with Definitive or Probable Invasive Fungal Infection (Summary Last Modified 01/98) Phase: Phase II, Phase I Type: Supportive care Status: Closed Age: 1 to 17 Sponsor: NCI Protocol IDs: NCI-97-C-0013
19.	Phase I/II Trial of Suramin in Adult Patients with AIDS-Related Kaposi's Sarcoma or Lymphadenopathy Syndrome Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NEDH-AIDS, NCI-T85-0081D, T85-0081
20.	Phase I/II Pilot Study of Amphotericin-B Lipid Complex in the Treatment of Hepatosplenic Candidiasis in Children with Neoplastic Disease Phase: Phase II, Phase I Type: Supportive care Status: Completed Age: 2 to 18 Sponsor: NCI Protocol IDs: NCI-92-C-0047B, NCI-T92-0001N, T92-0001
21.	Phase I/II Study of Anidulafungin in Immunocompromised Children With Neutropenia Phase: Phase II, Phase I Type: Supportive care Status: Completed Age: 2 to 17 Sponsor: NCI Protocol IDs: NCI-03-C-0229C, NCT00068471
22.	Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Completed Age: 18 and over Sponsor: NCI, NIH WGMCC Protocol IDs: 030205, 03-C-0205, CDR0000315356, NCT00064311
23.	Phase II Therapy with Suramin in Adult Patients with AIDS-Related Symptom Complex and Limited AIDS-Related Kaposi's Sarcoma Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 18 to 50 Sponsor: NCI Protocol IDs: MDA-DM-8486, NCI-T85-0045D, T85-0045
24.	Phase II Pilot Study of Therapy with Suramin in Patients with Early Kaposi's Sarcoma or Lymphadenopathy Syndrome Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: UCSF-240818-01, NCI-T85-0082R, T85-0082
25.	Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97) Phase: Phase II Type: Supportive care Status: Completed Age: any age Sponsor: NCI Protocol IDs: NCI-85-C-212C, NCI-T86-0036N, T86-0036